Category Archives: Stocks to Watch

Conflicts of Interest and the Public Trust

May 24, 2017

Umpires and referees are hired to impartially officiate their respective games, enforce the rules and ensure fair play. The credence of these officials builds public trust and protects the integrity of the games. Everyone complains that the ump or the ref got the call wrong, but seldom, if ever, does anyone suspect a conflict of interest or believe these officials received payments from players, managers or owners of the teams. If these officials weren’t trustworthy, it would shake the confidence and probity of sports to its core. It would demoralize fans and destroy the games. Billions would be lost by everyone involved with sports. It’s imperative for the very life of the games that these officials maintain honesty and integrity and avoid even the appearance of conflicts of interest. Appearances matter.

If appearances do matter, why then are officials nominated and confirmed to officiate a $23 trillion game? Jay Clayton, a longtime partner at the law firm Sullivan & Cromwell, is the latest nominee to lead the Securities and Exchange Commission. Clayton follows many other SEC heads with multiple intertwined conflicts of interest that bring impartiality into question in regulating Wall Street. Clayton has represented big banks like Goldman Sachs and Barclays as well as prominent hedge funds, corporate executives and numerous companies facing intense government scrutiny. Clayton’s numerous conflicts of interest, intertwined investments and problematic clients were recently chronicled in the New York Times article, Trump’s S.E.C. Nominee Disclosure Offers Rare Glimpse of Clients and Conflicts (http://dtn.fm/t1eD7).

There is no doubt that Clayton is highly experienced and possesses an expansive understanding of market machinations. His knowledge and experience are necessary to rise to the task of running a complex government agency that regulates a complex business that utilizes complex instruments. From inception the SEC has had leadership conflicts of interest.

In 1934, Franklin Roosevelt appointed Joseph Kennedy to head the newly created Securities and Exchange Commission. FDR viewed the SEC as a part of the national recovery from the Great Depression and believed Kennedy was an ideal candidate to rein in all those other Wall Street charlatans. Through experience, Kennedy knew all the fraudulent, questionable backroom ways of lining the pockets of finance’s fat cats, and many believed the fox had been appointed chairman of the hen house. During his two years as SEC chairman, Kennedy stopped many dishonest activities and closed as many loopholes as he could, but his real mission was to make corporations feel good again about doing business. Corporations didn’t trust FDR and the New Deal, but Joe Kennedy was one of them.

Just maybe the game is rigged to promote business. The stated mission of the SEC is to protect investors; maintain fair, orderly, and efficient markets; and facilitate capital formation. The SEC also states that it strives to promote a market environment that is worthy of the public’s trust. With the current and historic appointments made to the SEC and the glaring history of conflicts of interest, it’s obvious that the SEC isn’t promoting an environment worthy of the public’s trust. The SEC is promoting an environment worthy of only the corporations’ trust.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

BioCorRx, Inc. (BICX) Targeting Alcohol and Opioid Addiction with Innovative Two-Pronged Approach

BioCorRx (OTCQB: BICX) is the owner and creator of an innovative addiction treatment program used by a network of independent treatment centers to improve the lives of their patients struggling with alcohol and opioid addictions. The BioCorRx® Recovery Program leverages an innovative, two-pronged approach that addresses the underlying physical and behavioral issues associated with these addictions. The first half of this approach relies on a highly effective, proprietary implant formulation of the FDA-approved medication naltrexone, for which BioCorRx holds worldwide license rights (excluding Australia and New Zealand). The second half focuses on a modular counseling program coupled with overlapping peer support that is tailored specifically for those afflicted with alcohol and opioid addictions, helping to prepare them both physically and mentally for a life without these often dangerous substances.

America’s opioid epidemic is an increasingly treacherous issue that affects millions of people across the country. Per data from the Centers for Disease Control and Prevention, more than half a million people in the United States died from drug overdose from 2000 to 2015. Of those, more than 60 percent were linked to an opioid. Likewise, deaths from prescription opioids have more than quadrupled since 1999, driven by a nearly identical spike in the amount of prescription opioids sold. The negative implications associated with this addiction include traumatic life events for the addicted and their loved ones, as well as monumental financial expense. A 2010 study conducted by the American Society of Addiction Medicine found that addiction costs an estimated $700 billion annually in the U.S. alone.

Treating this growing problem has proven difficult. In 2011, the Substance Abuse and Mental Health Services Administration reported that 23.5 million persons aged 12 or older, roughly 9.3 percent of the population, needed treatment for an illicit drug or alcohol abuse problem. Of those, only 11.2 percent received the vital treatment at a specialty facility. BioCorRx aims to close this gap by both operating specialty facilities to aid those in need and providing a more thorough treatment program that’s been shown to lower patient drop-out rates, due to reduced cravings, and increase compliance rates, through automatic medication delivery and discreet outpatient treatment options.

In recent months, BioCorRx, through its BioCorRx Pharmaceuticals subsidiary, has looked to continue building on this proven medication through the clinical development of BICX101, a sustained release, injectable naltrexone for the treatment of opioid and alcohol use disorders. In early April, the company announced that three different formulations of the drug candidate showed success in reaching 28 days of sustained release in its preclinical studies, including one with an injection volume of just one milliliter. Following this result, BioCorRx formally requested a pre-IND meeting with the U.S. Food and Drug Administration as it continues to conduct additional studies in order to compile more data points.

In a business update issued earlier this month, Lourdes Felix, CFO, COO and director of BioCorRx, noted the strength of the company’s balance sheet following a March equity financing of $940,000 with accredited investors, as well as an investment of $1.7 million from Alpine Creek Capital Partners. Capital stemming from these transactions is expected to allow BioCorRx to continue executing on its business plan, including completion of “a few rounds of preclinical studies of BICX101” and accelerated sales and marketing activities related to its BioCorRx Recovery Program.

A strong balance sheet isn’t the only aspect of BioCorRx’s growth strategy about which prospective shareholders should be particularly optimistic. On May 16, the company announced its submission of a listing application for the Nasdaq Capital markets. The move comes less than two months after OTC Markets Group (OTCQX: OTCM) welcomed BioCorRx to the OTCQB Venture Market, which it reserves for early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process. The company will be required to meet a number of Nasdaq listing requirements in order to complete the uplist, but CFO Felix noted that members of BioCorRx’s management team “look forward to the prospect of a NASDAQ listing,” which they anticipate will “enhance BioCorRx’s visibility in the investment community to a larger market and provide for a broader, more diverse base of shareholders.”

Addressing the growing opioid epidemic in the United States, as well as lingering alcohol addiction issues, represents both an urgent call to action and a sizable market opportunity for companies offering proven effective treatment options. BioCorRx, through its innovative non-addictive medication-assisted treatment (MAT) program and promising clinical pipeline, represents an opportunity for the investment community to participate in the resolution of this crisis while capitalizing on the growth prospects of a leading edge health care solutions company.

For more information, visit www.BioCorRx.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Bitcoin Value Soars Despite SEC Rejecting ETF Bid, China Eyeing Trading Regulations

May 18, 2017

One of the most popular cryptocurrencies on the market, Bitcoin is reaching all-time highs on Asian trading platforms, despite recent challenges. The virtual currency has been rising in value, by 140 percent in 2016 and by roughly 50 percent in the past month alone, trading at over $1,800 on the Chinese market last week (http://dtn.fm/px7Ki). The value has dropped to around $1,700 in the meantime, but the cryptocurrency is expected to continue its growth, even if China is enforcing a series of Bitcoin trading regulations and Japan is considering the same.

One of the biggest challenges the digital currency is facing has to do with getting approval to be tied to an exchange-traded fund in the United States. Earlier this year, the U.S. Securities and Exchange Commission rejected a proposal to create a Bitcoin ETF on account of the lack of clear regulations on the markets where the cryptocurrency is traded (http://dtn.fm/EV7a8). The SEC said the lack of clear regulation on these markets raises concerns about potential manipulative or fraudulent practices in this market.

The application had been submitted by brothers Tyler and Cameron Winklevoss, who have been working on a proposed Bitcoin ETF for four years and have already won New York authorities’ regulatory approval for their virtual currency trading platform, Gemini Exchange. Other companies have also submitted approval request for Bitcoin ETFs to the SEC, and the commission may reach a different decision on those proposals, but approval is unlikely in the near future until more mature markets emerge.

Supporters of the digital currency had hoped that an ETF would help bring Bitcoin into the mainstream and make it available to retail investors via brokerage firms. The regulatory questions surrounding the currency have already deterred many financial institutions from investing significantly into Bitcoin, opting instead to focus on the underlying technology known as blockchain – a revolutionary concept that introduces a new way of processing financial transactions and keeping track of information.

Regulatory concerns over the cryptocurrency also exist on the Asian markets where Bitcoin is traded. China, responsible for almost 90 percent of all Bitcoin exchange trading, is imposing trading fees and controls, aimed at ensuring that bitcoin trading platforms are not becoming money laundering sites. A ban on cryptocurrency exchange withdrawals has also been enforced, and the country is also considering regulations that will require Bitcoin traders to register with their real names. The digital currency is being widely used by Chinese investors as a way of circumventing the country’s strict capital controls and minimizing the risk of significant losses caused by yuan deflation.

Japan, meanwhile, is taking rapid steps toward fully legitimizing the cryptocurrency, by announcing plans to allow interest-paying deposits for Bitcoin. The country has already declared Bitcoin a legal currency, establishing a platform for large corporations and institutional investors to participate in the local digital currency industry.

According to Sandeep Goenka, co-founder of one of India’s leading Bitcoin exchanges Zebpay, news of trading regulations on the two Asian markets and in Russia are partly what is driving the currency’s growth, Cointelegraph reports (http://dtn.fm/XO23d). Goenka believes that the stable growth rate is due to a global increase in awareness toward Bitcoin, as well as a growing demand from institutional investors. Instead of having a dampening effect, trading regulations will only help bring the cryptocurrency into the mainstream, says the Zebpay co-founder. In his opinion, the price of Bitcoin could reach $3,500 by the end of the year.

What the Future of SEC Enforcement Holds

May 16, 2017

The Dow Jones Industrial Average dropped 25 percent in the span of just four days during the stock market crash of 1929. The ‘29 crash was the worst in U.S. history, destroyed confidence in Wall Street and precipitated the Great Depression. The crash, the resultant financial malaise and shaken public confidence prompted calls for reform, and in 1934, the Securities and Exchange Commission (SEC) was created to restore public trust in capital markets and to oversee the conduct of those markets. Prior to the formation of the SEC, controls on issuing and trading of securities were virtually nonexistent, which allowed stock schemes and frauds to flourish. Rampant unrestricted margin trades and unreported concentrations of controlling interest led to abuses of power and market collapse. In total disregard of any ramifications, businesses, stock issuers and the exchanges essentially colluded and rigged markets to enrich themselves and their associates.

Attempting to restore order amid financial chaos, Congress passed legislation creating the Securities and Exchange Commission. The Securities Act of 1933 required public corporations to register their stock sales and make regular financial disclosures. The Securities Exchange Act of 1934 created the SEC to regulate exchanges, brokers, and over-the-counter markets, and the 1935 Public Utility Holding Company Act banned holding companies that obscured intertwined ownership.

The stated mission of the U.S. Securities and Exchange Commission is to protect investors, maintain fair, orderly, and efficient markets, and facilitate capital formation. Among its many duties, the SEC attempts to prevent market meltdowns by requiring transparency in financial instruments and by regulating stock issuers, brokerage firms and the major stock exchanges. It prohibits certain types of conduct, such as insider trading, and enforces laws that govern the financial industry. When necessary, the SEC enforces securities laws through a variety of means, including fines, referral for criminal prosecution, revocation or suspension of licenses, and injunctions. However, the SEC’s history of fair and equitable enforcement actions has often been called into question.

The Securities and Exchange Commission is a complex independent agency of the federal government which seeks to regulate complex financial instruments and markets. To chair or sit on the commission requires requisite skills and understanding of market complexities. Individuals typically tapped for appointment to the commission have extensive backgrounds, experience and relationships directly or tangentially related to the securities markets.

Herein is the rub… those that seek to regulate the markets and protect the public are cozied up with those that are often the bad actors requiring regulation. Much as during the financial crisis that promulgated the formation of the SEC, the largest market players operate with impunity and reap huge financial rewards. One need look no further than the lack of serious enforcement action (other than fines) after the mortgage shenanigans committed by large banks that led the financial crisis of 2007-2009. The SEC regulators were and still are from the same crowd that they purport to regulate and seem to always have multiple conflicts of interest.

What a conundrum. It requires experience and skill to effectively regulate the markets and its complexities, but those with the skill and experience to effectively regulate come from the very arena that needs oversight and carry luggage crafted from conflicts of interest.

The New York Times explores what the future of enforcement portends http://dtn.fm/40pqH under the latest nominee for chairman of the SEC and the conflicts of interest revealed by his financial disclosure form.

Financial Choice Bill Likely to Increase Insider Trading Risks for Small Investors

May 15, 2017

On May 4, 2017, after the House Financial Services Committee approved the Financial CHOICE Act of 2017 (FCA) in a 34-26 vote, Congress moved a step closer to replacing the Dodd-Frank Wall Street Reform and Consumer Protection Act. The bill will now be passed to the full House, proclaiming on the way its objective ‘to create hope and opportunity for investors, consumers and entrepreneurs by… holding Wall Street accountable’. However, many of its proposed changes appear to do the opposite. They hobble the SEC’s enforcement efforts: curtailing prosecutorial approaches and raising the bar for conviction by requiring stricter proof of wrongdoing. Even though other provisions increase the penalties for violations of securities laws, the FCA is likely to expose investors to increased market risk from fraudulent activity, including insider trading.

The scale of insider trading and the profits it promises are enormous. In 2014, for example, Mathew Martoma, a former portfolio manager at SAC Capital Advisors, was convicted for using confidential information to execute trades that yielded him $275 million, dubbed by former U.S. Attorney Preet Bharara, ‘as the “most lucrative” example of insider trading in history’ (http://dtn.fm/gZ5VK). Yet despite such staggering statistics, the FCA undermines the SEC’s ability to go after market manipulators like Martoma by including two provisions.

The first of these, which applies to the ‘standard of proof in administrative proceeding’, raises the bar by requiring the Commission to show ‘clear and convincing evidence’ that securities laws have been broken. This is a much more exacting standard than the ‘preponderance of the evidence’ standard required in federal courts and employed in SEC in-house hearings under existing rubric. Consequently, it is likely the SEC will decrease the number of cases pursued through administrative proceedings as it takes the path of least resistance.

Empowered by Frank-Dodd, in-house or administrative proceedings have proved to be a very effective enforcement tool for the SEC, so much so, that ‘according to a report (on May 9) by Cornerstone Research, the SEC filed 80 percent of its enforcement actions in the first half of fiscal year 2017 as administrative proceedings, not civil suits’, according to Reuters (http://dtn.fm/B1JQu).

The New York Times’ Deal Book explains (http://dtn.fm/RUn0O) this ‘attack on administrative proceedings’ as a ‘reaction to a provision of the Dodd-Frank Act that authorized the S.E.C. to pursue a wider range of penalties in cases filed with its own judges, which is usually a more expeditious procedure.’ The Deal Book story also questions ‘another provision (that) could allow defendants sued by the S.E.C. a means to challenge charges by claiming they had not been informed in advance of the theory of liability being pursued.’ The controversial provision referred to would ‘prohibit the S.E.C. from using “unproven legal theories” to establish a violation’, a clear sign that the FCA intends to keep insider training inside and not extend its penalties to outsiders.

Classic cases of insider trading occur when those who have obtained confidential information by reason of being a fiduciary of a corporation use that information to trade in the corporation’s securities. Such fiduciaries include directors and employees but also those who might temporarily become fiduciaries, such as attorneys, accountants, and consultants. However, in 1997, the Supreme Court, in United States v. O’Hagan, redefined insider trading. By ratifying the ‘misappropriation theory’, it cast a wider net of culpability when non-public information is used to trade securities.

O’Hagan was a partner in a law firm retained by a British company that planned to make a bid for the Pillsbury Company. Although, he was not assigned to work on that deal, O’Hagan learned about it over lunch. He, subsequently, began purchasing shares and options that netted him over $4 million in profits after the acquisition closed. Convicted at first instance of securities violations, the decision was reversed by an appellate court. On appeal by prosecutors, the Supreme Court held that an individual may be found liable for violating rule 10(b)-5, which forbids any fraud or deceit in connection with the purchase or sale of a security, by ‘misappropriating’ confidential information.

Now, any action to close the misappropriations route or make it more difficult for the SEC to take, might amount to declaring open season for insider trading.

At present, the law appears to allow an outsider to trade on confidential information, if the insider divulged the confidential information to the outsider because of friendship rather than for pecuniary gain, particularly if the outsider gave no undertaking that the information would not be used to trade. Indeed, in defending himself from ongoing SEC action, hedge fund billionaire Leon Cooperman is arguing ‘that even if he did get inside information, he did not agree to refuse to trade on it until after he’d already received it—and that therefore, the agreement was moot, from a legal standpoint’, according to Fortune magazine (http://dtn.fm/q2rA5). Cooperman, CEO of Omega Advisors, has been accused of making dozens of trades in Atlas Pipeline Partners securities in 2010, netting profits of $4 million, after learning from a company insider that the troubled oil and gas company was on the verge of a merger deal.

None of this bodes well for the financial markets. If Congress pursues its agenda of hamstringing the SEC, who will protect small investors?

BioCorRx (BICX) Offers New Hope for Individuals Addicted to Opioids, Alcohol

May 10, 2017

Addiction is a widespread crisis in the United States that doesn’t seem to have an end in sight. Both youth and adults suffer the devastating consequences of drug and alcohol addiction, and lives are lost and families are torn apart every day due to its destructive effects. In 2015 alone, more than 50,000 deaths resulted from drug overdoses in the U.S. (http://dtn.fm/2IdEz), but one company is offering new hope to millions of addicted individuals and their loved ones and making major strides to help turn the tide in America’s addiction epidemic.

BioCorRx Inc. (OTCQB: BICX) is an addiction treatment company engaged in developing and providing cutting-edge solutions to treat alcohol and opioid addictions. The company has pioneered a fresh approach to addiction treatment, offering a non-addictive, medication-assisted treatment (MAT) program that consists of two main parts: an outpatient implant procedure performed by a licensed physician and a specially tailored one-on-one counseling program.

The first component of the BioCorRx Recovery Program involves the insertion of an implant that delivers naltrexone to addiction patients. Naltrexone is a non-addictive opioid antagonist that is able to significantly reduce an individual’s physical cravings for opioids and alcohol. The presence of the implant and its ongoing delivery of naltrexone make part two of the BioCorRx Recovery Program possible: one-on-one counseling that is specifically designed to treat the substance abuse addictions of patients receiving long-term naltrexone treatment. Because their addiction cravings have been quelled by the naltrexone, patients are able to make greater progress in psychosocial treatment and can more effectively address the underlying issues driving their addictive behaviors. The result is a much greater chance for patients to achieve long-term sobriety.

BioCorRx CEO Brady Granier recently discussed this revolutionary new treatment program on FOX News (http://dtn.fm/aWB4K) and FOX Business (http://dtn.fm/jZg1Z), detailing the BioCorRx program and the success it is having among patients. Granier also discussed an injectable naltrexone option the company currently has in preclinical development. Through BioCorRx Pharmaceuticals, an R&D subsidiary of BioCorRx, the company is developing, in partnership with TheraKine LTD, a new injection delivery technology for naltrexone called BICX101. This injectable naltrexone offers an additional naltrexone delivery option for addicted individuals in treatment.

BioCorRx also recently announced it has entered into an agreement with DynamiCare Health, Inc. to develop a co-branded mobile application, called DynamiCare Rewards™, with BioCorRx CBT that supports patients who are in treatment for addiction. This app will provide patients with a self-guided, interactive version of the BioCorRx Recovery Program and will enable counselors to remotely monitor their patients’ progress as patients complete the 35 modules of the program.

The tremendous success of BioCorRx’s twofold addiction treatment program—addressing both the physical and psychological aspects of opioid and alcohol addiction—is offering fresh hope for addicted individuals and their loved ones throughout the country.

For more information, visit the company’s website at www.BioCorRx.com

Whistleblowers Finger Bad Actors in the Financial Markets and Get Paid Millions by the SEC for Doing So

Back in 1970, in a seminal paper titled The Market for Lemons, George Akerlof highlighted how vitally important accurate information was to the effective functioning of the financial markets. It stands to reason: if the information reported by firms cannot be trusted, few would want to invest. The obfuscation and fraud practiced at Enron, WorldCom and other entities in the 1990s and disguised under a façade of positive earnings reports provided devastating proof, however, that the markets had not developed effective mechanisms for tackling information asymmetry, which occurs when one party to a contract knows a great deal more than the other. The recent financial crisis provided further evidence. The triple-A credit ratings assigned by agencies such as Moody’s and Standard & Poor’s turned out to be ‘fake news’. In response, Congress passed the Dodd–Frank Act, which as part of its mandate to reform Wall Street and protect consumers instituted the Office of the Whistleblower under the aegis of the U.S. Securities and Exchange Commission.

Akerlof, in his insightful magnum opus, analyzed the role of information by examining the market for used cars, which has ‘peaches’ (good cars) and ‘lemons’ (bad ones). Since buyers are acutely aware that sellers of lemons are likely to pass off their cars as peaches, they lower their bids on all cars. This, however, drives many owners of good cars to take their peaches off the market. Naturally, those selling bad cars are unperturbed by the fall in prices and are quite happy to continue offering their lemons. The average quality of cars offered, consequently, falls, since there are less peaches but the same number of lemons. This initiates a vicious cycle, with buyers further lowering their bids and more peaches leaving the market. Akerlof’s insight was to show that informational asymmetry diminishes transactions in any marketplace by driving out quality. He went on to marry Janet Yellen, the present Chair of the Federal Reserve, in 1978 and to win the Nobel Prize in Economics for his work in 2001.

Despite the lament in a recent New York Times article (http://dtn.fm/bo07E) on the SEC’s apparent deafness when an employee at giant mortgage insurer Radiant Group complained his employer was materially understating estimates of claims liability, the Whistleblower program appears to have had some measure of success. In its 2016 Annual Report to Congress, the SEC announced that since its inception on August 12, 2011, the Whistleblower program had ‘awarded more than $111 million to 34 whistleblowers’, with one award in 2014 being worth a whopping $30 million. That’s an awful lot of money for blowing a whistle, and, although the program was designed to provide insiders with incentives to report bad behavior by their employers, the size of the payouts is beginning to attract the attention of outsiders as well.

The Gulf News (http://dtn.fm/aUn1G) tells how two vigilant analysts stand to win as much as $2.5 million after tipping off the SEC about discrepancies in the earnings reports of Texas-based medical device maker Orthofix International NV. Their million-dollar award will come out of the $8.25 million the errant company has to pay. They are not the only ones. In January 2016, the SEC paid ‘more than $700,000 to a company outsider who conducted a detailed analysis that led to a successful SEC enforcement action’. The agency has said that ‘just over a third of the more than $111 million awarded to whistle-blowers went to outsiders such as analysts or short-sellers’. Those numbers have increased. At May 2, 2016, approximately $154 million had been awarded to 44 whistleblowers.

The law requires whistleblower awards to be a minimum of 10 percent of monetary sanctions collected; however, they can go up to a maximum of 30 percent. With its Whistleblower program, the SEC is encouraging investors to do their due diligence and get paid for it. Hopefully, this will encourage market participants to keep their operations as clean as a whistle.

Navidea Biopharmaceuticals (NYSE: NAVB) Precision Immunodiagnostics, a Game Changer for Patients and Physicians

May 9, 2017

Precision medicine and precision diagnostics in particular play a major role in today’s medical world, by helping patients and physicians detect various diseases in time, which in turn allows for the proper treatments and care to be prescribed. Companies such as Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) are at the forefront of precision medicine, developing innovative immunodiagnostics and immunotherapeutic platforms that can make a real difference for patients suffering from serious ailments such as cancer or infectious, autoimmune or inflammatory diseases.

A leader in precision medicine via the development and commercialization of precision diagnostics and therapeutics based on immune system functions, Ohio-based biopharma company Navidea is working on multiple products built around its proprietary Manocept™ platform. The platform is based on the ability to target macrophages – a type of white cells essential to immune systems, whose main role is to detect microscopic foreign bodies or substances and eat them, for the detection, monitoring and treatment of specific diseases. Manocept™ is able to specifically target the CD206 mannose receptor present in targeted macrophages, allowing for enhanced flexibility and versatility and, ultimately, leading to increased diagnostic accuracy and improved targeted treatment and patient care.

The platform is at the core of Navidea’s flagship product, Lymphoseek®, a state-of-the-art, receptor-targeted radiopharmaceutical agent used for the mapping of lymphatic basis or the biopsy of sentinel lymph nodes in patients with different types of cancers. Administered as an injection of technetium Tc 99m tilmanocept, Lymphoseek® has been successfully used for diagnostics in patients with clinically node negative breast cancer, squamous cell carcinoma of the oral cavity or melanoma.

Lymphoseek® has been approved by the U.S. Food and Drug Administration and has been in use nationwide since its launch in 2013. Recently, Navidea sold American rights to the diagnostic tool to Cardinal Health Inc. (NYSE: CAH) for a guaranteed $100 million in payments over the next three years (http://dtn.fm/32PpG). The sale’s value could rise to $310 million throughout the life of the agreement. In addition, Navidea already has European distribution in place for the cancer diagnostic aid and is seeking further commercialization opportunities in the rest of the world.

Aside from Lymphoseek®, the company is looking for other ways to expand the use of its Manocept™ platform, for diagnostics across a wide range of disorders such as rheumatoid arthritis, Crohn’s disease, tuberculosis, Kaposi’s sarcoma and others. Navidea is already looking into expanding the targeted macrophages-based platform diagnostic for many of these disorders, with clinical studies underway for rheumatoid arthritis, cardiovascular disease and more.

Another potential use for the Manocept™ platform is the development of macrophage therapeutics using the Lymphoseek® delivery system. The company is currently working on the development of immunotherapeutics for cancer, inflammatory, autoimmune and infectious diseases and has so far reported encouraging results in preclinical trials, data suggesting several positive drug properties in terms of safety, duration of action, deliverability and costs. Results of animal testing have also indicated clear progress of macrophage therapeutics for various disorders including arthritis, asthma, Nonalcoholic Steatohepatitis-related inflammation, neuro-inflammation and multiple cancers.

For more information about Navidea Biopharmaceuticals and its innovative precision immunodiagnostic tools, visit the company’s website at www.Navidea.com

Medical Transcription Billing, Corp. (NASDAQ: MTBC) Set to Increase Revenues Substantially in 2017 with New Acquisition

May 8, 2017

The hiatus after its initial public offering (IPO) in 2014 has come to an end, and Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) has rebooted its acquisition strategy by bringing two new businesses under its wing. In late 2016, the company completed its acquisition of MediGain, LLC, a Texas-based medical billing specialist, and its subsidiary, Millennium Practice Management Associates, LLC, a New Jersey-based medical billing company. Now, with its bottom line enhanced as costs are spread over the larger organizational structure, MTBC is also set to see its top line improve substantially.

The MediGain acquisition will expand MTBC’s revenue base significantly, adding approximately 200 customers and $10 million in annualized revenues. As a result, for the first quarter of 2017, with an earnings report due on Wednesday, May 10, revenues are expected to rise by approximately 60% year-over-year to $8.2 million with “significantly improved” net loss and adjusted EBITDA. Overall revenue growth of over 20 percent is forecast for 2017, up from 2016 revenues of $24.5 million, and the top line is expected to hit $30 million.

The MediGain acquisition is a real feather in MTBC’s cap, bringing a number of advantages to the company. For starters, the purchase price of $7 million for $10 million worth of revenue represents a 30% discount on the industry norm multiple of 1x. As Warren Buffet famously said, “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”

Net present value of the acquisition is positive, as the discounted cash flows from the acquisitions exceed MTBC’s cost of capital, already noted by the market and reflected by a rise in the share price, and MTBC has gained talented team members in North America and expanded its Asia-based team to additional countries with talented, cost-effective workforces.

With these acquisitions, MTBC continues its focus on smaller one- to 10-doctor practices. The company provides software-as-a-service (SaaS) solutions to assist health care providers generate invoices, prepare and mail statements to their patients and submit insurance claims. It also provides electronic health record (EHR) software that allows providers to record notes of a visit and practice management software for the front office staff to schedule appointments, check insurance eligibility, send out automated reminder calls and text messages about flu shots, etc.

In addition to these services, practitioners and patients have access to a suite of mobile applications, including apps that the doctors can use to refill prescriptions and apps that the patients can use to look up their records, set up appointments, request prescription refills and check in when they arrive at the practice. Doctors who do not want to type their notes into the EHR can dictate into an app on their iPhone or Android device, which will be sent automatically to MTBC personnel, who will listen to it and type the notes into the electronic health record software.

MTBC’s main competitive advantage is its ability to deliver these services at a cost far less than any competitor. This is partly because MTBC has bought or established a number of overseas subsidiaries, sourcing expertise and talent for much less than is obtainable in the U.S. MTBC’s two largest offices are in Pakistan, where it employs 1,500 people at salaries of approximately one-tenth what you would pay in the United States for similarly skilled and educated labor.

For more information, visit www.MTBC.com

Code Green Apparel Corp. (CGAC) Puts Green in Your Bank, Green on Your Back

April 27, 2017

Environmentally friendly practices are becoming more and more important for industries that are trailed by long traditions of waste. Bringing fresh green practices to the apparel industry, Code Green Apparel Corp. (OTC: CGAC) is working to reduce the environmental impact of this industry by reclaiming textile waste that has heretofore rotted in landfills. Instead, this pre-consumer waste is now being recycled and reused in the making of new garments, with countless mounds and pounds of textile waste being diverted from the landfill and used in the creation of uniforms and other apparel products.

Code Green Apparel’s recycling technology accomplishes multiple enviro-friendly aims. In reclaiming cotton from those huge mounds of textile waste, the company is not only reducing and reusing waste but is simultaneously saving massive amounts of water. While cotton is one of the most desirable textiles on earth, it is also one of the thirstiest crops, and it can take thousands of gallons of water to grow the amount of cotton needed to make just one shirt or pair of pants. By recycling the cotton from textile waste, Code Green Apparel is saving huge amounts of water that would have otherwise been consumed in growing fresh cotton crops. Not only is Code Green Apparel recycling cotton from massive amounts of textile waste, but the company is imbuing polyester and other fabric blends with new life as well.

Once Code Green Apparel returns textile waste to its original form, it is handled in the same way as any other textile at a typical garment manufacturing facility. What’s more, the apparel products created from this recycled material have the same look, feel, and performance quality of a non-recycled clothing item. In weaving yarns and sewing fabrics, the company adheres to the same industry standards as any other apparel manufacturer. The difference is, of course, that environmental harm is significantly reduced thanks to Code Green Apparel’s green and sustainable practices.

There is also one other notable difference: Code Green Apparel’s uniforms and products are less expensive than non-recycled apparel items. The company’s factory direct business model lets businesses purchase uniforms for their employees at a lower cost than would be incurred if purchasing non-recycled apparel. The environment wins, and so do American businesses!

For more information about Code Green Apparel, its practices and products, visit www.CodeGreenApparelCorp.com

How Quest Resource Holding Corp. (NASDAQ: QRHC) Plans to Use Business Waste to Fuel Triple-Digit, Top-Line Growth

Humans are a wasteful bunch, and our habits in the business world are no different. While a minimal amount of waste in the workplace is recycled, Texas-based Quest Resource Holdings (NASDAQ: QRHC) believes the nation’s corporations can do a lot better. As a provider of sustainability, recycling and environmental services, Quest is focused on strengthening its own top line while helping large corporations reduce their operating cost and minimize their eco-footprint.

Through its Quest Resource Management Group and Early911 subsidiaries, Quest designs and manages sustainability, recycling and resource management programs for the automotive, grocery/restaurant, industrial, property management and sustainability industries. With more than 38,000 client locations across the country, Quest has managed more than 1.37 million tons of waste, including used motor oil, trash, organics, used tires and card board.

In January 2017, Quest expanded its reach into the construction and demolition (C&D) industry, which spent $1.18 billion in 2016 alone – marking the industry’s highest level of spending in a decade. According to the Department of Commerce, the increase correlates with rising demand for project services and waste management as construction companies seek to minimize risk and cost, increase insight and control, and address environmental goals of clients.

For Quest, this means opportunity. Quest leverages its national footprint and cloud-based service and reporting platform to provide clients the ability to control cost, access waste disposal alternatives, streamline logistics, and increase efficiencies. Using the C&D industry as an example of this strategy, Quest’s construction-centered offerings include general requirement services such as temporary offices, storage containers, toilets and hand washing stations, holding tanks, water tanks and dumpsters. C&D waste and recycling services include solutions for materials such as wood, concrete, roofing, drywall, metal, plastic and blast media recycling, as well as hazardous and non-hazardous waste.

These solutions are executed through a time-saving, streamlined process in which Quest handles incoming requests, schedules and manages services, and provides LEED® credit tracking and sustainability reporting, enabling busy construction managers to focus on building their projects.

To facilitate its own growth, Quest operates an organic and acquisition-based strategy that creates a base of recurring revenues generated through fees for waste and recycling services, the sale of recyclable material in the commodity market, professional services, and the sale of operational products such as waste collection containers, compacting equipment and fleet maintenance products.

In 2016, backed with a credit facility with up to $20 million in borrowing capacity, the company refined its go-to-market strategy to optimize its market opportunities and reinforce the foundation for growth. The plan enabled the expansion of existing markets, entry into new industry verticals, and wins from new and existing customers.

These initiatives enabled the company to drive fourth-quarter revenues to $45.0 million, a year-over-year increase of 2%. Full-year 2016 revenues of $184 million represent an increase of 8% from total revenues in 2015. In the fourth quarter of 2016 the company also improved its gross margin by 50 basis points to 8.2%, and narrowed its net loss to $1.3 million compared to $2.8 million for the comparable quarter of 2015.

Pivoting off this growth, the company has its sight set on a market opportunity valued at $55 billion, with anticipation for continued momentum.

“We expect improved performance in 2017, reflecting our refocused go-to-market strategy and our efforts to enhance the value add of our services portfolio. Those initiatives, including our focused approach to customer acquisition, are expected to result in 1% to 2% improvement in gross margin and positive Adjusted EBITDA by the end of 2017,” S. Ray Hatch, president and CEO of Quest, stated in the earnings release. “Long term, we expect our strategy will return the company to double-digit top-line growth. In addition, we plan to show continued growth during the next several years and have established a three-to-five-year gross margin target in the low to mid-teens and an Adjusted EBITDA margin target of 4% to 6%.”

For more information visit www.qrhc.com

OTC Markets Group Announces Proposed Changes to OTCQB Standards; Comment Period Underway

April 20, 2017

OTC Markets Group has announced the publication of proposed amendments to the OTCQB Standards, which are scheduled to go into effect May 18, 2017.

Among these proposed changes, OTC Markets Group proposes the addition of new eligibility criteria for companies not required to be SEC reporting. OTC Markets Group further purposes the refining of various continued eligibility requirements and the reorganization of several sections for improved clarity.

Companies following the Alternative Reporting Standard may now become qualified for the OTCQB and will be required to make public disclosure available through the OTC Disclosure & News Service in accordance with the OTCQX and OTCQB Disclosure Guidelines, which are the same disclosure guidelines used by OTCQX companies. In addition, these Alternate Reporting Companies will have certain corporate governance requirements.

Other proposed changes relate to the timing for removing delinquent filers, revision of due dates for International Reporting filings, annual certification of good standing in the state or jurisdiction of incorporation, and the procedures for removing a company from OTCQB for bid price deficiency.

A comment period is ongoing through May 17, and those with feedback regarding the proposed changes should send their comments and questions to mike@otcmarkets.com.

The proposed rules can be read in their entirety at http://dtn.fm/4EywP

RenovaCare, Inc. (RCAR) Leading Innovation in Wound Care Treatment

April 13, 2017

The global wound care market recently reached revenues of more than $20 billion (http://dtn.fm/W1wjB) at the end of 2016, based on sales at the manufacturer’s level. Specifically, the burn care market is expected to grow at a CAGR of 6.8% from $1.68 billion in 2016 to more than $2.33 billion by the end of 2021 (http://dtn.fm/I6abR). The growth in these markets has been largely attributed to factors such as the rising number of burn accidents, an aging population, and the rise in cardiovascular diseases, diabetes, obesity, and other diseases that can cause skin-related problems.

Currently, wound care ranges from anti-infectives, ulcer wound management, moist dressings, and negative pressure wound therapy to wound closure and even conventional skin grafts. These treatments can be extremely painful, slow-to-heal, and are more likely to face complications along the way. Today, more is being done to help patients suffering from skin problems, some of which include a rise in health care expenditure, more government initiatives, an increase in the number of emergency centers and burn units, and a growing understanding of the various treatment options.

In addition, more innovative forms of treatment are slowly being introduced. RenovaCare, Inc. (OTCQB: RCAR), a development stage biotechnology company focused on acquiring, researching, developing, and commercializing first-of-their-kind self-donated stem cell therapies for the regeneration of human organs, is in the process of developing a product that targets issues relating to the human body’s largest organ, the skin.

The company’s CellMist™ system uses a patient’s own stem cells and is applied onto wounds and burns using its SkinGun™. The technology is able to regrow the skin across wounds by spreading numerous regenerative islands over the affected area, rather than the wound healing from the outside in. Although still part of an experimental setting, the system has been tested on patients such as Matt Uram, a victim of a fire-related accident during a July fourth celebration, who, within three days witnessed incredible results, with burns almost completely healed and no risk of infection or scarring (http://dtn.fm/uXAR5).

RenovaCare believes the SkinGun™ could replace today’s standards of care, decreasing the need for patients to go through the process of having complicated skin grafts, mesh skin grafts, and other forms of painful treatment.

The company is aiming to get the SkinGun™ FDA-approved in the near future, and research is already underway at RenovaCare to enable the treatment of third degree burns, which are more complex in nature and often come with damage to the muscles and tissue below the skin.

For more information, visit www.RenovaCareInc.com

Marina Biotech, Inc. (MRNA) Sets Further Development of Drug Candidates IT-102 and IT-103, Signs Windlas Healthcare Manufacturing Agreement

April 7, 2017

Marina Biotech Inc. (OTCQB: MRNA) filed a 10K with the SEC on April 5, 2017, for its year ended December 31, 2016. The late stage biopharmaceutical company summarized its achievements in 2016 and provided an outlook into its 2017 performance, including its planned clinical trials in 2018. Marina Biotech specializes in creating and commercializing innovative therapies for treatments of cancer, hypertension, and arthritis.

The firm plans to move by the first quarter of 2018 into a phase 3 clinical study of its drug candidate, IT-102, a fixed dose combination (FDC) bi-layer tablet, said Joseph Ramelli, chief executive officer of Marina Biotech. It recently signed an agreement for Windlas Healthcare Limited to manufacture the tablet, positioning Marina Biotech for the Phase 3 study. That India-based firm has facilities that are approved by the Food & Drug Administration (FDA) in the U.S., as well as the European Union Good Manufacturing Practices (EU cGMP).

The company also reported:

  • Marina Biotech expanded its unsecured credit line from its chairman, Dr. Vuong Trieu, on April 4, 2017, for an additional $500,000. The initial line was for $540,000 secured last November. The company had drawn down $250,000 of that by December 31, 2016. The company also secured another line of credit from Autotelic, Inc., for the commercialization of IT-102 and IT-103.
  • The company announced that it has completed its merger with IThena Pharma, enabling it to advance its development of combination tablets for arthritis, pain, cancer and hypertension. The transaction with IThena Pharma has put in motion a new pipeline by Marina Biotech that advances its development of combination therapies.
  • Marina Biotech announced the results of new preclinical and clinical data for its drug candidates IT-102 and IT-103. These results support the further development of both for the treatment of hypertension/pain, Ramelli said. Among these results was the indication that IT-102 and IT-103 could serve as unique anticancer agents.
  • In February of 2017 the company entered into a licensing agreement with LipoMedics, under which Marina Biotech could receive up to $90 million in milestone payments which are success based. Under that agreement, Marina Biotech gave a license to LipoMedics for its SMARTICLES platform for the delivery of nanoparticles, including small molecules.

For more information, visit www.MarinaBio.com

AzurRx BioPharma, Inc. (NASDAQ: AZRX) Overcoming Current Exocrine Pancreatic Insufficiency Treatment Limitations

March 31, 2017

Exocrine Pancreatic Insufficiency, or EPI, is a problem in a person’s digestive system. Simply put, EPI is when the pancreas cannot produce enough of the enzymes that the body requires to break down and absorb nutrients. Unfortunately, this means that the body is unable to absorb the right fats and nutrients, often leading to weight loss.

There are a number of causes for EPI, such as inflammation of the pancreas; effects from surgery on the pancreas, intestines, or stomach; or even an inherited disease such as cystic fibrosis, Shwachman-Diamond syndrome, Crohn’s Disease, diabetes, or celiac disease. Symptoms do vary, but normally the patient will feel a pain or tenderness in the abdomen, problems with bowel movements, flatulence, and a feeling of being full.

Today, there has been a rise in the number of people with EPI, and this has been largely attributed to an increase in the number of patients diagnosed with diabetes and cystic fibrosis (CF). According to an article from PR Newswire (http://dtn.fm/uyF9L), there are approximately 70,000 people living with cystic fibrosis worldwide, with 1,000 new cases diagnosed each year. In addition, 50% of children with CF suffer from EPI from the moment they are born.

According to TransparencyMarketReserarch.com (http://dtn.fm/0tvSc), the EPI market is growing at an astronomical rate, and this is not expected to slow, since the number of patients diagnosed with diabetes is expected to grow to approximately 366 million by the end of 2030. PR Newswire reported an anticipated expansion of the market at a CAGR of over 8% between 2015 and 2023, allowing it to reach just under $3 billion.

Unfortunately, despite the expected market growth, current EPI treatments have a number of limitations. Aside from a healthy diet, the current treatment for EPI is Pancreatic Enzyme Replacement Therapy (PERT), but not only are these treatments not very effective, they also show a lack of stability in an acidic environment and carry a high pill burden, which can be highly inconvenient for patients.

Luckily, AzurRx BioPharma, Inc. (NASDAQ: AZRX), a development stage biopharmaceutical company focused on creating treatments for patients suffering from gastrointestinal diseases such as EPI, is currently in Phase IIa of the development of MS1819 lipase, a non-systemic, yeast-derived recombinant enzyme.

This orally-administered capsule is not only showing significant potential for the treatment of EPI in patients with chronic pancreatitis and cystic fibrosis; it is also demonstrating activity in long chain fats and stability in protease and bile salt environments. MS1819 lipase could give patients suffering from EPI the chance to reduce their pill burden from 25 to 40 pills a day to as little as five to eight.

For more information, visit the company’s website at www.AzurRx.com

MeetMe, Inc. (NASDAQ: MEET) Closes on 9.2 Million Share Public Offering, Sees 2Q2017 Target on Acquisition of if(we)

March 29, 2017

MeetMe, Inc. (NASDAQ: MEET) has closed on its public offering of 9.2 million shares of common stock at $5 per share. This is inclusive of the full option by underwriters for 1.2 million additional shares of common stock. Net proceeds will be used by the company for general corporate purposes and to potentially fund MeetMe’s pending acquisition of “if(we)”, a San Francisco-based social and mobile technology company, as well as other future takeovers.

MeetMe is a social network for meeting new people in the U.S. Some 80% of its one million daily user traffic comes from mobile devices, such as iPhones, iPads, and Android devices. It is becoming a gathering place for mobile users, the company said. It generates revenue from advertising, subscriptions, and virtual currency.

Targeted to close in 2Q2017, the “if(we)” acquisition would be made for $60 million in cash, and that company is anticipated to generate at least $9 million of adjusted EBITDA and be accretive to earnings in the first 12 months after closing, MeetMe noted in a news release.

“if(we)” had revenues of $44 million in 2016 and is the operator of TAGGED and Hi5, branded apps which enable people to meet and chat with others. The site features 10.4 million mobile chats daily, and 18,000 mobile app users are added each day. “if(we)” is available in 100 countries and 15 languages.

MeetMe said in its corporate presentation on the acquisition (http://dtn.fm/J4gAA) that the transaction is expected to generate cross-promotional opportunities. It added that there is a less than 5% overlap in user bases, and the two companies together can lower technology costs by standardizing products. Also, by utilizing MeetMe’s best practices, the company expects a convergence of certain key metrics, such as daily chats.

Funding for the acquisition will come from MeetMe’s cash on hand, cash from operations, and a new $30 million loan from J.P. Morgan. The combined company could generate revenues of $150 million annually and an EBITDA of $50 million, per MeetMe’s presentation materials.

For more information, visit www.MeetMeCorp.com

Greenkraft, Inc. (GKIT) Making Itself Available to the Entirety of the United States

March 28, 2017

Most vehicles across the United States are powered by either gasoline or diesel, but this is changing. Sales of cars, especially fleet vehicles, that operate on alternative fuels are growing, and, according to the U.S. Department Of Energy, natural gas now powers more than 150,000 vehicles across the country and over 15 million vehicles worldwide (http://dtn.fm/LF8Zg).

Because natural gas as a transportation fuel is widely distributed, domestically available, more cost efficient, and better for the environment, these new vehicles are expected to become increasingly popular for the foreseeable future, and, thanks to Greenkraft, Inc. (OTCQB: GKIT), they will soon be making their way across the U.S.

Greenkraft, a company that manufactures and markets alternative fuel systems to convert petrol-based vehicles and engines to function on natural gas and propane fuels, offers a variety of trucks and engines to suit various modern-day business needs. In fact, all of its products are built to suit companies in the food, electric, construction, and landscaping markets, among others.

Greenkraft prides itself on offering fuel efficient trucks that not only save businesses money, but are also better for the environment. These vehicles meet EPA and CARB emission standards and use only alternative fuels for power. To top it off, the company works closely with the government to encourage businesses to switch to more eco-friendly automobiles through tax incentives and rebates.

Most recently, Greenkraft announced that it will be launching a widespread national marketing campaign to include printed advertisements, trade shows, and targeted campaigns that will showcase its trucks and engines to the majority of the U.S. market. In addition to bringing in new customers, GKIT wants to educate companies about the positive environmental impact they could have by changing their transportation methods.

A month prior to this press release, the company announced that, due to increased demand for its products, it will be expanding to a bigger factory in 2017 and introduce new, larger-sized trucks in weights of 26,000 and 33,000 pounds, respectively. The combination of this new nationwide marketing campaign and its plans to expand to a bigger factory will enable GKIT to meet customer needs while having a serious positive impact on the environment.

For more information, visit www.GreenkraftInc.com

Heat Biologics (NASDAQ: HTBX) at the Vanguard of a Paradigm Shift in Cancer Treatment

March 24, 2017

The human body is elegantly designed to heal itself, utilizing the immune system as its defense against various pathogens. Triggered by immune response signals, the immune system attacks and kills organisms and substances that invade body systems and cause disease. However, the immune system sometimes needs help in identifying and killing some invaders.

Cancer presents a complex and perplexing problem for effective immune system response, because it finds ways to hide from the immune system or block the immune system’s ability to battle against the disease. An important part of the immune system is its ability to differentiate between normal cells in the body and invaders. This differentiation allows the immune system to attack the invading cells while leaving normal cells alone. To achieve this, the immune system uses molecules on certain immune cells that need to be activated or inactivated to trigger an immune response. However, cancer cells can sometimes use these checkpoints to deceive the immune system and avoid being attacked. Newly developed drugs, known as checkpoint inhibitors, have shown some success in cancer treatments. However, a combination of checkpoint inhibitors and specific T cell-stimulating therapeutic vaccines indicates a much higher degree of efficacy.

Heat Biologics (NASDAQ: HTBX) is at the vanguard of this shift in cancer treatments, developing novel therapeutic vaccines to activate the immune system against a wide range of cancers. When antigens enter the body, they stimulate the immune system to produce antibodies in response to these foreign substances. Heat Biologics exploits this natural process to elicit a powerful immune response against the disease target. The company’s therapeutic vaccines are based on heat shock protein gp-96, a protein that activates the immune system when cells die. This protein is attached to the cell by what’s called a KDEL leash. Heat Biologic’s vaccines remove this leash and cause cells to continuously secrete gp96 and its chaperoned antigens to activate the immune system.

Heat Biologics recently announced the latest results of its ongoing phase 2 clinical trial in combination with Bristol-Myers Squibb’s checkpoint inhibitor. Researchers reported a strong correlation between T cell activation, tumor reductions, and increased overall survival in the patients evaluated. Patients with a sustained immune response also exhibited substantial tumor reductions. It appears the combination of Heat Biologics’ vaccine and checkpoint inhibitors may become an attractive therapeutic approach treating cancers.

For more information, please visit www.HeatBio.com

Cannabis Businesses Represent Diverse Opportunities of Booming Market

March 21, 2017

The U.S. medical and recreational marijuana industry continues to expand. Even though the debate over medical efficacy and the concerns over recreational marijuana use continue to cause political and social divisions within the country, the investment community is moving rapidly from benign interest to embracing the marijuana industry as a significant investment opportunity.

At the recent 29th annual ROTH conference, an investment conclave attracting global financial gurus, even traditionally conservative industries like private equity groups took serious consideration of the marijuana market opportunities. The opening conference panel discussion centered on the medical uses for marijuana and emphasized the upside potential in the burgeoning marijuana market that is already underway.

In attendance at the conference and presenting to fund managers and investment advisors was GrowGeneration Corporation (OTC: GRWG). GrowGeneration currently owns and operates 12 specialty retail hydroponic and organic gardening stores with locations in Colorado, Nevada and California. With the company’s focus on owning and operating branded stores in all of the major legalized cannabis states, it currently sells thousands of products to facilitate the cultivation of marijuana for commercial and home growers.

GrowGeneration went public last year and is fast moving toward its objective of becoming the first company in its vertical on the NASDAQ stock exchange. Interviewed at the conference, Darren Lampert, CEO of the company, stated in part, “Investors are seeking out investments in the cannabis industry and are hoping to profit from the fastest growing new market in the USA in some time. GrowGeneration benefits from all sides as more growers come to us for their equipment and nutrients, which is why we were able to grow as exponentially as we have without directly touching the end product.” By supplying a vast array of specialty retail hydroponic equipment, lighting, and organic nutrients and soils to horticulturalists and marijuana cultivators, GrowGeneration is focused on reaping rewards from the explosive growth of this fledgling industry.

Already one of the nation’s largest specialty retail hydroponic and organic gardening store chains, GrowGeneration acquired all of the assets of Sonoma Hydro last month creating a $2.5 million northern California retail distribution center. Northern California’s “Emerald Triangle,” home to a large concentration of cannabis cultivators, is a significant growth opportu­nity for the company, with the market projected to grow at a compounded annual rate of 18.5%, reaching $6.5 billion by 2020.

Further validation of the huge potential of this market can be found in GrowGeneration’s press release last week. The company announced that Merida Capital Partners, a cannabis infrastructure fund, has provided GrowGeneration $1.65 million in equity financing. When factoring in warrant exercises, funding will total $3.92 million in capital. Merida Capital Partners priced callable warrants at $4.12 or higher, an obvious indication of its belief in the company.

Whether one agrees with the surge in the cannabis industry or not, there’s no denying the wizards of Wall Street are believers. Now may be the time for individual investors to participate and potentially profit from one of the fastest growing new markets in America, which is occupied by a number of other innovators such as: MyDx, Inc. (OTCQB: MYDX), which offers CannaDX, a unique device that allows anyone to directly test cannabis products for THC, CBD, and CBN potency; Innovative Industrial Properties, Inc. (NYSE: IIPR), which focuses on an entirely different aspect of the industry, helping licensed MMJ growers meet capital needs by purchasing their grow-land and leasing it back to them; Terra Tech Corp. (OTCQX: TRTC), which designs and sells its own specialized hydroponic and associated equipment for indoor growing, in addition to the retail selling of cannabis products; and Aphria, Inc. (OTCQB: APHQF), which produces and sells a variety of “100% Greenhouse Grown” cannabis products throughout Canada.

Neogen Corp. (NEOG) Keeping People and Animals Safe with Traditional Lab Methods

March 17, 2017

Foodborne illnesses are more common than people believe. These infections are not only common but costly, and also very preventable. Every year, one in six Americans get sick from consuming the wrong food or drink. Unfortunately, because there are so many different microbes and pathogens that can cause disease, there are also many different types of infections.

With more than 250 different foodborne diseases now described, each has its own set of symptoms, and some have lethal results. Normally, a person contaminated will suffer from temporary nausea, vomiting, abdominal cramps, or diarrhea, but because of the variety of bacteria, viruses, and parasites found in certain foods, these contaminated foods can also cause long-term health problems, or even death.

The hardest aspect of food safety is controlling the various times at which food can get contaminated. The food supply process today is extremely complicated and comes with its own set of very strict rules. However, there are many opportunities for food contamination to take place. These include on-farm production, harvesting or slaughtering, processing, storage, transport, and distribution.

Neogen Corp. (NASDAQ: NEOG) a company that develops, manufactures, and markets various products and services relating to food and animal safety, has, for its mission, to be the leading food and animal safety company, keeping people and animals safe throughout the food making and marketing process.

The company keeps food and animals safe from inside the farm gate through to the moment it arrives on people’s plates. From intervention products to diagnostic products, NEOG provides test kits, instrument systems, consumables, culture media, software, and services for the food safety market. It also provides a complete line of veterinary diagnostics, instruments, pharmaceuticals, nutritional supplements, disinfectants, and rodenticides for the safety of animals.

Although many companies today have replaced traditional lab methods with more modern test formats, Neogen still believes in the time-tested methods discovered and developed in the mid-1800’s. The company serves this market with its Acumedia dehydrated culture media lines and competes in each segment of the Food Safety market. It now has some of the world’s top food and animal producers and processors as clients, and offers more than 400 products to the market.

For more information, visit the company’s website at www.Neogen.com

UGE International Ltd. (UGEIF) Guided by Corporate Motto of “Be Green, Be Great, Have Fun”

UGE International Ltd. (OTCQB: UGEIF) delivers distributed renewable energy solutions to commercial and industrial customers around the world. The company provides full-service renewable energy solutions using industry-leading technology and delivers affordable, sustainable, and reliable energy to business enterprises.

The company has four lines of business that seamlessly dovetail to deliver end-to-end renewable energy solutions that are easy to manage and don’t interfere with customer business continuity. The company’s business lines include: consulting and project management, engineering and design, development, and turn-key EPC (engineering, procurement and construction).

UGE provides consulting and project management services in all aspects of solar photovoltaic services such as site feasibility studies, financial analysis of the project, local electric authority submittals and approvals, building permits, power and energy production verification, equipment procurement and more.

The company’s engineering and design line of business sets high standards for comprehensive detail and design of renewable energy projects and includes, among others, optimal solar array layout, complex grid interconnection design, ground-mount and rooftop system design and electrical, civil, geotechnical and structural design.

Under the company’s development line of business, UGE can finance and develop complete ground and rooftop photovoltaic solutions. The company has relationships with energy cooperatives and municipalities and facilitates rooftop and ground-mount site procurement. UGE has technical expertise with knowledge and experience in the development process and has access to capital and take-out partners to address financial concerns.

The company’s turn-key EPC line of business provides complete services to manage project execution from start to completion, which includes full turn-key services such as engineering and design, equipment evaluation and procurement, construction and contractor management, system commissioning and system monitoring.

UGE International focuses on multiple markets in the United States, Canada, Panama, China and the Philippines. The company was named among the Top Solar Contractors by Solar Power World, and it has over 330 MW of solar energy experience. UGE’s dedication to excellence is reflected in its motto, “Be Green, Be Great, Have Fun,” and has catapulted the company toward becoming a world leader in distributed renewable energy.

For more information, please visit http://www.ugei.com

ImageWare Systems, Inc. (IWSY) Sets March 30 Conference Call, Receives Frost & Sullivan Award for New Product Innovation

ImageWare Systems, Inc. (OTCQB: IWSY) has set a March 30, 2017, conference call (http://dtn.fm/4j16M) for a corporate update on its fourth quarter and year ended December 31, 2016. Results for those periods will be released prior to the call, which is scheduled for 5 p.m. (ET). Hosting the call will be Jim Miller, ImageWare chairman and CEO, and Wayne Wetherell, CFO.

The San Diego-based company designs cloud-based and mobile multi-modal biometric identity management solutions, including biometric authentication technology. Its biometrics are next generation and are interactive and scalable cloud-based solutions. The company offers multi-factor authentication for desktop devices, smartphones, and mobile clients. Its products include authentication by face, voice, fingerprint, eye, DNA, and more. It also develops access control tools.

ImageWare recently received the 2017 North American Frost & Sullivan Award for New Product Innovation. The award was presented in recognition of its GoVerifyID Enterprise Suite, which provides multi-modal biometric user identification as an end-to-end turnkey solution.

“This mobile/cloud SaaS (software as a service) offering is the industry’s first multi-modal biometric user authentication solution that allows customers to strengthen the security of their passwords or two-factor authentication using biometrics. Rather than typing a password, end users can speak a passphrase, swipe their fingerprints, or even take ‘selfies’ to gain access,” Frost & Sullivan noted in a news release.

It also cited ImageWare’s GoVerifyID Enterprise Suite, which is Windows Server certified. It noted that this product is device-agnostic and allows user authentication via the cloud. Additionally, Frost & Sullivan said, ImageWare has shown speed in response to market needs in the fast changing world of identity management.

For more information, refer to www.IWSInc.com

Vertex Energy, Inc. (NASDAQ: VTNR) Focused on Used Oil Recycling

The foundation of Vertex Energy, Inc. (NASDAQ: VTNR) was laid by the employment of a 16-year-old Alabama teenager, with the result being that a multi-faceted environmental services company was eventually built upon the endeavors of that teenager. Roughly 30 years ago, Benjamin Cowart, now the CEO and chairman of Vertex, began work at his brother’s used oil collection business in Alabama. After 15 years of working, learning, and helping to build a successful business, he ventured out on his own and formed Vertex in 2001. Vertex Energy now collects and recycles used motor oil and other petroleum by-products, off-specification commercial chemicals, and multiple other industrial waste streams.

Vertex purchases used oil, industrial waste, and chemical products from a developed network of local and regional suppliers, known as street collection, and focuses resources on recycling a portion of its collected used motor oil and other petroleum products. Vertex also sells used petroleum products as feedstock to other re-refineries and fuel blenders or as replacement fuel for use in industrial burners.

The company’s Black Oil division operates across the entire used motor oil recycling spectrum. From used oil and petroleum product collection and aggregation, the company transports, stores, refines, and sells re-refined products to end users. The company’s Refining and Marketing division aggregates feedstock, re-refines it, and then sells the various products. The company’s Recovery division delivers solutions for the recovery and management of hydrocarbon streams.

Expanding feedstock, Vertex Energy has acquired several other used oil collection routes. At oil’s peak, Vertex Energy was paying local generators $1.00 per gallon for used motor oil, but, with the collapse in oil prices, Vertex was able to move from paying for used oil to charging for collection. Vertex has been challenged like others in the oil business but has targeted 2017 as the year for its collection acquisitions to play out.

Headquartered in Houston, Texas, with facilities in Louisiana and Ohio, and offices in Illinois and Georgia, Vertex Energy has come a long way from that Alabama teenager.

For more information, please visit www.VertexEnergy.com

Extreme Networks, Inc. (NASDAQ: EXTR) Enters Asset Purchase Agreement for Avaya Networking, Subject To Bankruptcy Court Approval

March 15, 2017

Extreme Networks, Inc. (NASDAQ: EXTR) has entered into an asset purchase agreement for Avaya Networking, Inc. totaling $100 million, subject to adjustments. In January 2017, Avaya and certain of its subsidiaries filed for Chapter 11 bankruptcy in the Southern District of New York. Extreme Networks’ offer is subject to court approval. The company defined its offer in an 8K SEC filing on March 7, 2017 (http://dtn.fm/t3joR).

Extreme Networks, Inc. is a networking company based in San Francisco. It designs, builds and installs ethernet computer network products. It is a software-driven company that enables IT departments of clients to build stronger relationships with customers, employees, and partners. The company maintains more than 20,000 customers in some 80 countries. A key asset for Avaya is its award-winning fabric switching technology. Switching fabric typically includes data buffers.

Extreme Networks’ asset purchase agreement comes as a result of potential synergies with Avaya Networking, Inc., as identified by the EXTR management team. Extreme Networks believes it offers complementary products between the two businesses across the company’s vertical markets. For Extreme Networks’ clients, the deal, if court approved, would offer technology for edge switching environments in addition to secure access to Avaya’s data center. For Avaya, selling its networking business is seen by its management as a positive move, enabling it to focus on its unified communications core.

Extreme Networks believes that, if the offer is consummated, it could result in $200 million of added revenues annually. The acquisition is expected to be accretive to its own earnings and cash flow beginning in fiscal 2018. Extreme Networks intends to update its quarterly guidance and revenue if the acquisition is approved.

The tentative agreement remains subject to better offers, as Avaya plans to make a motion to the court to initiate a bidding and public auction process. On execution of the purchase agreement, Extreme Networks placed $10 million in escrow. Pending approval, these funds will be applied to the purchase of Avaya’s assets, but not to any of the firm’s liabilities. If the deal is not approved, Extreme Networks may be entitled to court-approved termination fees.

For more information, visit www.ExtremeNetworks.com

BioVie, Inc. (BIVI) Develops New Approaches to Devastating Liver Diseases

It’s estimated that over one million Americans and millions more worldwide suffer from liver cirrhosis. Globally, it accounted for over 1.2 million deaths in 2013, and it’s the 12th leading cause of death by disease in the United States, where 27,000 Americans die each year from the disease. Worldwide, 57 percent of cirrhosis is attributable to either hepatitis C or hepatitis B. Long-term alcohol abuse accounts for about 20 percent of cirrhosis-related deaths globally, while, in the United States, 40 percent of cirrhosis-related deaths are caused by alcohol abuse. Each of these disease drivers triggers the replacement of normal liver tissue with damaged scar tissue, which impedes blood flow and the liver’s ability to clean and purify blood.

Liver cirrhosis has multiple potential causes and often more than one of them can be found in the same patient. The disease’s most common complication is ascites, which is the abnormal accumulation of fluid in the abdomen, often accompanied by kidney dysfunction. This life-threatening condition causes severe suffering, frequent infections, and multiple complications that can lead to a painful death.

Currently, no approved medications to treat ascites are available. Diet change and drugs used off-label can provide some initial symptomatic relief, but, as the disease worsens, response rates fall. About 40 percent of patients die painfully within two years of diagnosis. The treatment costs for liver cirrhosis, including ascites and other complications, are deemed to be in excess of $4 billion annually in the U.S. alone.

The unquestioned human and financial toll of liver cirrhosis on patients, families, and society has created a real need for treatment solutions. One development stage biotechnology company, BioVie, Inc. (OTCQB: BIVI), is pioneering just such innovative treatment solutions. BioVie actively pursues the discovery, development, and commercialization of innovative drug therapies for liver diseases. Just four months ago, BioVie submitted an Investigational New Drug (IND) application for its initial drug candidate, BIV201, to the U.S. Food and Drug Administration (FDA). This new drug has the potential to become the first drug approved by the FDA to treat ascites due to chronic liver cirrhosis and could become the breakthrough treatment so desperately needed around the world.

For more information, visit www.BioVieInc.com

Archives

Select A Month
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search

    Categories

    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (33)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • AlphaTrade.com APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • Barchart.com (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • BizRocket.com Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • Bollente Companies, Inc. BOLC (2)
  • BoonMarket.com (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises, Inc. CDII (39)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  • Chineseinvestors.com, Inc. CIIX (23)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • Connect-A-Jet.com CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (160)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (73)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • EFoodSafety.com Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz Inc. EPAZ (22)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Etelcharge.com Inc. ETLC (3)
  • Ethema Health Corporation GRST (7)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (81)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  • Fund.com, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • GainClients Inc. GCLT (9)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Payout Inc. GOHE (38)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • GotStocks.net (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • Greenstone Holdings Inc. GSHN (2)
  • GREM USA GRMU (2)
  • Grey Cloak Tech, Inc. GRCK (4)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital, Inc. IGC (18)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • InMed Pharmaceuticals, Inc. IMLFF (6)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (9)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kootenay Zinc Corp. KTNNF (5)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Loans4Less.com Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Transcription Billing Corp. MTBC (13)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • MGX Minerals, Inc. MGXMF (4)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (48)
  • Money4Gold Holdings Inc. MFGD (3)
  • MortgageBrokers.com Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (62)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • MyStaru.com Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • National Waste Management Holdings Inc. NWMH (24)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (19)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One Step Vending Corp. KOSK (2)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,352)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • ORHub, Inc. ORHB (6)
  • OTCPicks.com (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (78)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • PetroSun Inc. PSUD (41)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Player's Network, Inc. PNTV (3)
  • Players Network PNTV (4)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProBility Media Corp. PBYA (11)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (551)
  • QualityStocks Stock Newsletters (18,170)
  • QualityStocks Video Charts (286)
  • QualityStocks.net Market Basics (6)
  • QualityStocksNewsBreaks (16)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (74)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Skinny Nutritional Corp. SKNY (19)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • Smallcaps.us (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stealth Technologies, Inc. STTH (3)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,884)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune, Inc. TPIV (15)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.